To describe a novel case of intraocular tuberculosis (TB) arising in a patient undergoing treatment for Vogt–Koyanagi–Harada disease, and to highlight the use of spectral domain optical coherence tomography for helping confirm the diagnosis and monitor treatment response.
Case report of a patient with Vogt–Koyanagi–Harada disease on prednisone, with acute clinical changes suspicious for bilateral tuberculous choroiditis. Spectral optical coherence tomography, fundus photography, and B-scan ultrasonography were all used to capture the acute lesions, and to monitor their responses after initiation of anti-TB therapy.
New subretinal lesions arose bilaterally, as characterized by spectral domain optical coherence tomography, and appeared to regress after a first round of anti-TB therapy, thereby helping confirm the presumed diagnosis of intraocular TB. A new peripheral choroidal lesion arose shortly after temporary cessation of antimicrobial treatment, and again regressed once four-drug therapy was instituted, with no recurrent lesions thereafter.
The use of multimodal imaging was instrumental in the management of a rare case of intraocular TB arising in the setting of underlying Vogt–Koyanagi–Harada disease.